A Pharmacovigilance Officer is dedicated to ensuring the ongoing safety of therapeutic products by systematically monitoring and evaluating adverse effects reported by patients and healthcare providers. Their role involves gathering detailed safety data, assessing causality, and identifying any potential risks that may arise during a product’s use in the general population. Through careful analysis of this information, they help detect new safety signals and contribute to updating risk-benefit assessments. Collaboration with regulatory bodies and internal teams is key to maintaining compliance with global safety standards and ensuring timely reporting of adverse events. They also play a proactive role in promoting a culture of safety by educating healthcare professionals and patients about reporting processes.
Pharmacovigilance Officers are responsible for preparing comprehensive safety documentation, including Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs). They also develop and implement safety monitoring protocols and train staff on adverse event reporting requirements. Staying current with changing regulations and safety guidelines enables them to adapt processes effectively and maintain rigorous safety surveillance. Their work plays a vital role in protecting patient health by ensuring that any emerging risks are promptly identified and managed throughout the product’s lifecycle. By continuously enhancing safety monitoring systems, they help maintain public trust in healthcare products and contribute to safer therapeutic outcomes.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India